MedTrace Logo

Surgical Site Infection Study

NCT01449669 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 14

Last updated 2014-02-10

No results posted yet for this study

Summary

The purpose of this study is to investigate the pharmacokinetics of cefazolin using both plasma and microdialysate sampling methods in children with single ventricle physiology undergoing their second palliation procedure. This will provide data to determine if the current standard dosing regimen of cefazolin is adequate to achieve and maintain tissue concentrations greater than the minimum inhibitory concentrations (MIC) for common post-surgical pathogens that cause Surgical Site Infections (SSIs).

Conditions

  • Cava-pulmonary Anastomosis

Sponsors & Collaborators

Principal Investigators

  • Todd Kilbaugh, MD · Children's Hospital of Philadelphia

Eligibility

Min Age
3 Months
Max Age
6 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2013-04-30
Completion
2014-02-28

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01449669 on ClinicalTrials.gov